| Marianna Freudzon, MD | |
|
333 Cedar St, Yusm Department Of Dermatology, New Haven, CT 06510-3206 | |
| (203) 785-4632 | |
| Not Available |
| Full Name | Marianna Freudzon |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 10 Years |
| Location | 333 Cedar St, New Haven, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073931564 | NPI | - | NPPES |
| 1073931564 | Other | INDIVIDUAL |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Southeast Permanente Medical Group | 6204829013 | 576 |
News Archive
Novelos Therapeutics, Inc., a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced that it is developing CLR1502 (GLOW2), a preclinical cancer-targeted optical imaging agent for intraoperative tumor margin illumination and non-invasive tumor imaging.
Patients with malfunctioning kidneys often need dialysis to rid their blood of unwanted molecules and excess water.
Listen to the political rhetoric around the contraception mandate, and you might think that employers must provide women with free birth control of every kind. It's not quite that simple.
Would banning ventilated filters on cigarettes protect public health? Scientists from multiple institutions, including a group of addiction neuroscience researchers from the Virginia Tech Carilion Research Institute, are gathering evidence under funding from the National Institutes of Health's National Cancer Institute to potentially inform a U.S. Food and Drug Administration (FDA) decision about whether to recommend design changes to filtered cigarettes.
› Verified 5 days ago
| Entity Name | The Southeast Permanente Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245266956 PECOS PAC ID: 6204829013 Enrollment ID: O20040407000370 |
News Archive
Novelos Therapeutics, Inc., a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced that it is developing CLR1502 (GLOW2), a preclinical cancer-targeted optical imaging agent for intraoperative tumor margin illumination and non-invasive tumor imaging.
Patients with malfunctioning kidneys often need dialysis to rid their blood of unwanted molecules and excess water.
Listen to the political rhetoric around the contraception mandate, and you might think that employers must provide women with free birth control of every kind. It's not quite that simple.
Would banning ventilated filters on cigarettes protect public health? Scientists from multiple institutions, including a group of addiction neuroscience researchers from the Virginia Tech Carilion Research Institute, are gathering evidence under funding from the National Institutes of Health's National Cancer Institute to potentially inform a U.S. Food and Drug Administration (FDA) decision about whether to recommend design changes to filtered cigarettes.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marianna Freudzon, MD 3495 Piedmont Rd Ne Bldg 91, Atlanta, GA 30305-1717 Ph: (404) 365-0966 | Marianna Freudzon, MD 333 Cedar St, Yusm Department Of Dermatology, New Haven, CT 06510-3206 Ph: (203) 785-4632 |
News Archive
Novelos Therapeutics, Inc., a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced that it is developing CLR1502 (GLOW2), a preclinical cancer-targeted optical imaging agent for intraoperative tumor margin illumination and non-invasive tumor imaging.
Patients with malfunctioning kidneys often need dialysis to rid their blood of unwanted molecules and excess water.
Listen to the political rhetoric around the contraception mandate, and you might think that employers must provide women with free birth control of every kind. It's not quite that simple.
Would banning ventilated filters on cigarettes protect public health? Scientists from multiple institutions, including a group of addiction neuroscience researchers from the Virginia Tech Carilion Research Institute, are gathering evidence under funding from the National Institutes of Health's National Cancer Institute to potentially inform a U.S. Food and Drug Administration (FDA) decision about whether to recommend design changes to filtered cigarettes.
› Verified 5 days ago
Robert E Tigelaar, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 15 York St, Dermatology, Lci Room 609, New Haven, CT 06510 Phone: 203-785-4632 Fax: 203-785-3315 | |
Michael Girardi, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 15 York St, New Haven, CT 06510 Phone: 203-785-4632 Fax: 203-785-3315 | |
Dr. Noah Hornick, MD, PHD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 150 Sargent Dr Ste 2, New Haven, CT 06511 Phone: 203-503-3000 | |
Antonio Subtil Deoliveira Jr., MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 800 Howard Ave, Yale Physicians Building, New Haven, CT 06519 Phone: 203-785-2140 | |
Dr. Mary Escherich Laird, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2 Church St S, New Haven, CT 06519 Phone: 203-785-4445 Fax: 203-776-6188 | |
Leonard M Milstone, MD Dermatology Medicare: Medicare Enrolled Practice Location: 800 Howard Ave, Yale Physicians Building, New Haven, CT 06519 Phone: 203-785-2140 |